When Joe DeMayo’s donated kidney started to fail earlier than expected, he didn’t know that the drug he was taking could’ve left him vulnerable — and that one of the most formidable drug regulators in the world may have failed to protect him.
https://www.propublica.org/article/fda-tacrolimus-kidney-transplant-patient?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post